118 related articles for article (PubMed ID: 12525573)
21. Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells.
Franco R; Lillo A; Rivas-Santisteban R; Reyes-Resina I; Navarro G
Cells; 2021 May; 10(5):. PubMed ID: 34066933
[TBL] [Abstract][Full Text] [Related]
22. Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke.
Fang Y; Ren R; Shi H; Huang L; Lenahan C; Lu Q; Tang L; Huang Y; Tang J; Zhang J; Zhang JH
Aging Dis; 2020 Dec; 11(6):1496-1512. PubMed ID: 33269103
[TBL] [Abstract][Full Text] [Related]
23. Neurochemistry of Enteric Neurons Following Prolonged Indomethacin Administration in the Porcine Duodenum.
Czajkowska M; Całka J
Front Pharmacol; 2020; 11():564457. PubMed ID: 33013401
[TBL] [Abstract][Full Text] [Related]
24. Association of Brain-Gut Peptides with Inflammatory Cytokines in Moyamoya Disease.
Han W; Jin F; Zhang H; Yang M; Cui C; Wang C; Jiang P
Mediators Inflamm; 2020; 2020():5847478. PubMed ID: 32410857
[TBL] [Abstract][Full Text] [Related]
25. Vagal Nerve Stimulation Attenuates Ischemia-Reperfusion Induced Retina Dysfunction in Acute Ocular Hypertension.
Jiang MN; Zhou YY; Hua DH; Yang JY; Hu ML; Xing YQ
Front Neurosci; 2019; 13():87. PubMed ID: 30804746
[No Abstract] [Full Text] [Related]
26. Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease.
Van Bulck M; Sierra-Magro A; Alarcon-Gil J; Perez-Castillo A; Morales-Garcia JA
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30743990
[TBL] [Abstract][Full Text] [Related]
27. Subclinical Lipopolysaccharide from
Mikołajczyk A; Złotkowska D
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30717384
[TBL] [Abstract][Full Text] [Related]
28. PACAP deficiency as a model of aging.
Reglodi D; Atlasz T; Szabo E; Jungling A; Tamas A; Juhasz T; Fulop BD; Bardosi A
Geroscience; 2018 Dec; 40(5-6):437-452. PubMed ID: 30345481
[TBL] [Abstract][Full Text] [Related]
29. Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases.
Carniglia L; Ramírez D; Durand D; Saba J; Turati J; Caruso C; Scimonelli TN; Lasaga M
Mediators Inflamm; 2017; 2017():5048616. PubMed ID: 28154473
[TBL] [Abstract][Full Text] [Related]
30. Current disease modifying approaches to treat Parkinson's disease.
Lindholm D; Mäkelä J; Di Liberto V; Mudò G; Belluardo N; Eriksson O; Saarma M
Cell Mol Life Sci; 2016 Apr; 73(7):1365-79. PubMed ID: 26616211
[TBL] [Abstract][Full Text] [Related]
31. Microglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In Vivo.
Morara S; Colangelo AM; Provini L
Neural Plast; 2015; 2015():135342. PubMed ID: 26273481
[TBL] [Abstract][Full Text] [Related]
32. Microglia and inflammation: conspiracy, controversy or control?
Fernandes A; Miller-Fleming L; Pais TF
Cell Mol Life Sci; 2014 Oct; 71(20):3969-85. PubMed ID: 25008043
[TBL] [Abstract][Full Text] [Related]
33. Microglial VPAC1R mediates a novel mechanism of neuroimmune-modulation of hippocampal precursor cells via IL-4 release.
Nunan R; Sivasathiaseelan H; Khan D; Zaben M; Gray W
Glia; 2014 Aug; 62(8):1313-27. PubMed ID: 24801739
[TBL] [Abstract][Full Text] [Related]
34. The controversial role of microglia in malignant gliomas.
Wei J; Gabrusiewicz K; Heimberger A
Clin Dev Immunol; 2013; 2013():285246. PubMed ID: 23983766
[TBL] [Abstract][Full Text] [Related]
35. PACAP attenuates NMDA-induced retinal damage in association with modulation of the microglia/macrophage status into an acquired deactivation subtype.
Wada Y; Nakamachi T; Endo K; Seki T; Ohtaki H; Tsuchikawa D; Hori M; Tsuchida M; Yoshikawa A; Matkovits A; Kagami N; Imai N; Fujisaka S; Usui I; Tobe K; Koide R; Takahashi H; Shioda S
J Mol Neurosci; 2013 Oct; 51(2):493-502. PubMed ID: 23720065
[TBL] [Abstract][Full Text] [Related]
36. Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE.
Tan YV; Abad C; Wang Y; Lopez R; Waschek JA
PLoS One; 2013; 8(4):e61200. PubMed ID: 23613811
[TBL] [Abstract][Full Text] [Related]
37. Emerging neuropeptide targets in inflammation: NPY and VIP.
Chandrasekharan B; Nezami BG; Srinivasan S
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G949-57. PubMed ID: 23538492
[TBL] [Abstract][Full Text] [Related]
38. PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice.
Watson MB; Nobuta H; Abad C; Lee SK; Bala N; Zhu C; Richter F; Chesselet MF; Waschek JA
Neuroscience; 2013 Jun; 240():277-86. PubMed ID: 23500093
[TBL] [Abstract][Full Text] [Related]
39. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Ringer C; Büning LS; Schäfer MK; Eiden LE; Weihe E; Schütz B
Neurobiol Dis; 2013 Jun; 54():32-42. PubMed ID: 23466699
[TBL] [Abstract][Full Text] [Related]
40. Systems Biological Approaches Reveal Non-additive Responses and Multiple Crosstalk Mechanisms between TLR and GPCR Signaling.
Krishnan J; Choi S
Genomics Inform; 2012 Sep; 10(3):153-66. PubMed ID: 23166526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
